S. 4118: Hospice Care Accountability, Reform, and Enforcement Act of 2026
The "Hospice Care Accountability, Reform, and Enforcement Act of 2026" introduces various changes aimed at improving hospice care in the United States. The main provisions of the bill include:
Moratorium on New Hospice Programs
The bill proposes a five-year moratorium on the enrollment of new hospice programs. This moratorium can be lifted in certain areas where there is a clear geographic need for additional hospice services. The intent behind this is to stabilize the existing hospice care market before allowing new entities to enter.
Enhanced Oversight and Payment Structures
This legislation seeks to enhance oversight of the hospice care sector. It includes provisions for adjusting payment structures related to hospice services. These adjustments aim to ensure that hospice care providers adhere to certain standards and that their operations are sustainable and financially accountable.
Independence of Certifications
One of the key elements of the bill is to ensure the independence of the certifications for terminal illness under Medicare. This means that the process for certifying individuals as terminally ill should be free from conflicts of interest, ensuring that patients receive appropriate care based on their medical conditions.
Amendments to the Social Security Act
The bill outlines specific amendments to the Social Security Act that pertain to palliative care and hospice services. Key aspects include:
- Enhanced guidelines for treatment supervision to ensure patients receive the necessary care and attention.
- Implementation of payment caps to control costs and prevent excessive billing practices by hospice providers.
- Establishment of care plans that outline the treatment regimen for patients receiving hospice care, promoting individualized and compliant care delivery.
Overall Goals
The overall aim of the legislation is to enhance the delivery and regulation of hospice care services. It strives for a balance between ensuring patient access to essential treatments and maintaining cost-effectiveness and quality oversight in the hospice care system.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Mar. 17, 2026 | Introduced in Senate |
| Mar. 17, 2026 | Read twice and referred to the Committee on Finance. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.